Supernus Pharmaceuticals Inc (NAS:SUPN)
$ 45.13 +0.68 (+1.53%) Market Cap: 2.62 Bil Enterprise Value: 2.28 Bil PE Ratio: 0 PB Ratio: 2.43 GF Score: 87/100

Supernus Pharmaceuticals Inc (SUPN) Transcripts

  • 1